Exodus Point Capital Management, LP Viracta Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $13.1 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 19, 2022
SELL
$1.87 - $5.0 $54,132 - $144,740
-28,948 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$2.23 - $4.76 $64,554 - $137,792
28,948 New
28,948 $138,000
Q2 2021

Aug 16, 2021
SELL
$7.55 - $12.95 $456,344 - $782,736
-60,443 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$7.58 - $18.67 $458,157 - $1.13 Million
60,443 New
60,443 $559,000

Others Institutions Holding VIRX

# of Institutions
43
Shares Held
9.39M
Call Options Held
5.9K
Put Options Held
0
View Full List

About Viracta Therapeutics, Inc.

VIRX Quotes by TradingView
  • Ticker VIRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,558,200
  • Market Cap $20.3M
  • Description
  • Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...
More about VIRX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email